Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Mindfulness Meditation to Reduce Cognitive Load

2. november 2026 oppdatert av: Jean Neils-Strunjas, University of South Carolina

Mindful Meditation to Reduce Stress and Cognitive Load for Older Adults

Older adults from disadvantaged backgrounds may score lower on memory and thinking tests because of test anxiety and stress, not because of true memory problems. This can lead to being wrongly diagnosed with dementia. This study will test whether a short, 15-minute guided meditation before taking a memory and thinking test helps older adults do better on the test and feel less stressed. About 60 adults age 50 and older, with lower education and income levels, will take part. Participants will be randomly assigned to either listen to a guided meditation or listen to a neutral story for 15 minutes before taking the test. The study will measure stress using heart rate, blood pressure, saliva samples, and a stress questionnaire.

Studieoversikt

Detaljert beskrivelse

This pilot study examines whether a brief mindfulness meditation intervention, administered immediately before cognitive testing, can reduce measurement bias caused by test-related anxiety in older adults from low-income, low-education backgrounds. Participants are randomized to a 15-minute guided mindfulness meditation session or a 15-minute neutral story-listening control session, both administered immediately before the Montreal Cognitive Assessment (MoCA). Physiological stress markers (heart rate variability, blood pressure, salivary pH) and self-reported anxiety (State-Trait Anxiety Inventory) are assessed to evaluate the intervention's effect on stress. Assessments and physiological data collection are administered via a custom application developed by the study team, which standardizes test administration and scoring.

Studietype

Intervensjonell

Registrering (Antatt)

60

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studiesteder

    • South Carolina
      • Columbia, South Carolina, Forente stater, 29201
      • Columbia, South Carolina, Forente stater, 29201
        • University of South Carolina, Aging Gracefully Lab
        • Ta kontakt med:
      • Kingstree, South Carolina, Forente stater, 29556
        • Vital Aging of Williamsburg County, Inc
        • Ta kontakt med:
      • West Columbia, South Carolina, Forente stater, 29169
        • Brookland-Lakeview Empowerment Center
        • Ta kontakt med:

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

50 år og eldre (Voksen, Eldre voksen)

Tar imot friske frivillige

Ja

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  • Age 50 years or older
  • Self-identified low educational attainment (high school diploma or less)
  • Low socioeconomic status per local criteria
  • Able to provide informed consent

Exclusion Criteria:

  • Diagnosis of dementia
  • Uncorrected hearing impairment preventing completion of the audio-guided intervention
  • Uncorrected vision impairment preventing completion of the Montreal Cognitive Assessment (MoCA)
  • Current regular mindfulness meditation practice
  • Diagnosis of atrial fibrillation

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Diagnostisk
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Enkelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Mindfulness Meditation

Participants complete a 15-minute guided mindfulness meditation session immediately before completing the Montreal Cognitive Assessment (MoCA).

A 15-minute audio-guided mindfulness meditation session delivered via the study application, administered immediately before cognitive testing.

Aktiv komparator: Story-Listening Control

Participants listen to a 15-minute neutral, non-mindfulness story immediately before completing the Montreal Cognitive Assessment (MoCA).

A 15-minute audio recording of a neutral, non-mindfulness-based story delivered via the study application, administered once immediately before cognitive testing.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Change in MoCA Total Score
Tidsramme: Immediately following the 15-minute intervention session (single study visit)

Cognitive performance measured using the Montreal Cognitive Assessment (MoCA), ranging from 0 to 30, with higher scores indicating better cognitive performance, administered by an examiner immediately after the assigned 15-minute intervention session.

Immediately following the 15-minute intervention session (single study visit)

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Change in Heart Rate Variability
Tidsramme: Baseline to immediately post-session

Change in heart rate variability measured continuously via the study application before and during the assigned intervention session.

Baseline to immediately post-session
Change in Systolic Blood Pressure
Tidsramme: Baseline to immediately post-session

Change in systolic blood pressure measured via automated cuff before and immediately after the assigned intervention session.

Baseline to immediately post-session
Change in Salivary pH
Tidsramme: Baseline to immediately post-session

Change in salivary pH measured via test strips before and immediately after the assigned intervention session.

Baseline to immediately post-session
Change in State-Trait Anxiety Inventory Score
Tidsramme: Baseline to immediately post-assessment

Change in self-reported state anxiety measured using the State Anxiety subscale of the State-Trait Anxiety Inventory (STAI), a 20-item scale ranging from 20 to 80, with higher scores indicating greater state anxiety, administered at baseline and immediately after the assigned intervention session.

Baseline to immediately post-assessment
Change in Perceived Stress Scale (PSS-10) Score
Tidsramme: Baseline to immediately post-assessment

Change in self-reported perceived stress measured using the 10-item Perceived Stress Scale (PSS-10), ranging from 0 to 40, with higher scores indicating greater perceived stress, administered at baseline and immediately after the assigned intervention session.

Baseline to immediately post-assessment
Recruitment Rate
Tidsramme: Up to 4 months

Percentage of eligible individuals screened who agree to enroll in the study.

Up to 4 months
Retention Rate
Tidsramme: Day 1

Percentage of enrolled participants who complete their assigned study visit.

Day 1
Intervention Adherence
Tidsramme: Day 1

Percentage of participants who complete the full 15-minute assigned intervention session (mindfulness meditation or story-listening control), as recorded by the study application

Day 1
Participant Acceptability
Tidsramme: Day 1

Acceptability assessed via a 3-item investigator-developed measure: (1) enjoyment of the session, (2) comfort during the session, (3) perceived health benefit. Each item is rated on a 3-point scale (No / Neutral / Yes) and reported individually.

Day 1
Task Feasibility (Participant-Reported)
Tidsramme: Day 1

Feasibility assessed via a 2-item investigator-developed measure: (1) physical ease of the seated/lying position, (2) clarity of the recorded audio instructions. Each item is rated on a 3-point scale and reported individually.

Day 1

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Antatt)

14. november 2026

Primær fullføring (Antatt)

15. mars 2027

Studiet fullført (Antatt)

15. mars 2027

Datoer for studieregistrering

Først innsendt

8. september 2026

Først innsendt som oppfylte QC-kriteriene

2. november 2026

Først lagt ut (Faktiske)

9. november 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

9. november 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

2. november 2026

Sist bekreftet

1. november 2026

Mer informasjon

Begreper knyttet til denne studien

Ytterligere relevante MeSH-vilkår

Andre studie-ID-numre

  • STUDY00000925
  • CL034115600N230020280007408 (Annet stipend/finansieringsnummer: University of South Carolina-Columbia)

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

UBESLUTTE

IPD-planbeskrivelse

Data sharing plans have not yet been finalized. As a pilot study with a small sample size (n=60), the investigators will determine after study completion whether de-identified individual participant data will be made available, and if so, under what conditions (e.g., data use agreement, timeframe, and mechanism of access).

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere